April 06, 2018
Artificial Intelligence and National Security
Partially autonomous and intelligent systems have been used in military
technology since at least the Second World War, but advances in machine
learning and Artificial Intelligence (AI) represent a turning point in the
use of automation in warfare. Though the United States military and
intelligence communities are planning for expanded use of AI across their
portfolios, many of the most transformative applications of AI have not yet
been addressed.
In this piece, we propose three goals for developing future policy on AI
and national security: preserving U.S. technological leadership, supporting
peaceful and commercial use, and mitigating catastrophic risk. By looking
at four prior cases of transformative military technology—nuclear,
aerospace, cyber, and biotech—we develop lessons learned and recommendations
for national security policy toward AI.
Read the full article at the Belfer Center
More from CNAS
-
Biotech Matters: Public-Private Coordination of Biotechnology
Reports
An appreciation of biotechnology’s great opportunities is, for many commentators, intimately joined with regret about a disconnect between the U.S. government and the private ...
By Richard Danzig
-
$6.6 billion TSMC deal in Arizona the latest in the CHIPS Act’s rollout
Podcast
“President Biden signed the CHIPS and Science Act just about 20 months ago, which in government time is yesterday. And they’ve hired 200 people,” said Vivek Chilukuri, a senio...
By Vivek Chilukuri
-
Response to NTIA Request for Comment: “Dual Use Foundation Artificial Intelligence Models with Widely Available Model Weights”
Commentary
In February 2024, the Department of Commerce’s National Telecommunications and Information Administration (NTIA) issued a Request for Comment (RFC) on the implications of “ope...
By Caleb Withers
-
Biotech Matters: Great Data Competition and Interoperability with Allies and Partners
Reports
Understanding and strengthening America’s biotechnology leadership requires exploring the limits of existing data relevant to the U.S. bioeconomy so that policymakers and the ...
By Michelle Holko
